分组1 - Guardian Pharmacy Services reported quarterly earnings of $0.37 per share, exceeding the Zacks Consensus Estimate of $0.27 per share, and up from $0.24 per share a year ago [1] - The company achieved a revenue of $397.62 million for the quarter, surpassing the Zacks Consensus Estimate by 2.41%, compared to $338.57 million in the same quarter last year [3] - Over the last four quarters, Guardian Pharmacy has exceeded consensus EPS estimates three times and topped revenue estimates four times [2][3] 分组2 - The stock has increased by approximately 11.8% since the beginning of the year, while the S&P 500 has declined by 0.9% [4] - The current consensus EPS estimate for the upcoming quarter is $0.24 on revenues of $336.07 million, and for the current fiscal year, it is $1.10 on revenues of $1.41 billion [8] - The Medical - Drugs industry, to which Guardian Pharmacy belongs, is currently ranked in the top 36% of over 250 Zacks industries, indicating a favorable outlook [9]
Guardian Pharmacy Services (GRDN) Surpasses Q4 Earnings and Revenue Estimates